British Pharmacopoeia 2027 (BP 2027)
British Pharmacopoeia 2027 (BP 2027)
The British Pharmacopoeia 2027 edition
Setting the standard for tomorrow
New, legally enforced standards available from 1 August 2026.
The BP 2027 edition supersedes the BP 2026 and becomes
legally effective on 1 January 2027 with all European Pharmacopoeia
texts included.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of
authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs, which are legally enforced by the Human
Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients
sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are
reproduced in the BP, making the BP a convenient and fully comprehensive set of
standards that can be used across Europe and internationally.
New for the BP 2027 edition
- 18 new BP monographs and all new texts added with
- Issues 12.1 to 13.1 of the Ph. Eur.*
- One new infrared reference spectrum has been added
- to the collection
- 13 new BPCRS
- 132 amended BP texts
Anmelden
| ISBN | 978-3-7692-8781-3 |
|---|---|
| Medientyp | Buch - Schuber |
| Auflage | 1. |
| Verlag | Deutscher Apotheker Verlag Dr. Roland Schmiedel GmbH & Co. KG |
| Anzahl Bände | 6 |
| Format | 40,0 x 29,5 cm |
| Sprache | Englisch |
